Three-dimensional (3D) bioprinting has developed over the last ten years into one of the most promising technological methods in tissue engineering, regenerative medicine, and pharmaceutical testing. The ability to make biologically functional structures by carefully placing cells and biomaterials opens up new ways to solve important global problems, such as organ shortages and the limits of traditional in vitro models. However, bioprinting technologies are still not widely used because commercial systems are often too expensive and complicated for institutions in developing countries to use.
Publication Date: 2026-06-19